Previsioni di mercato dei kit per test rapidi in Europa fino al 2030 - Analisi regionale - per tipo (test rapido dell\'antigene, test rapido degli anticorpi e altri), prodotto (kit di test rapido da banco e kit di test rapido professionale), tecnologia (test a flusso laterale, Fase solida, agglutinazione, test immunospot e basati su componenti cellulari), applicazione (test della glicemia, test delle malattie infettive, gravidanza e fertilità, test cardiometabolici e altri) e utente finale (ospedali e cliniche, assistenza domiciliare, centri diagnostici, e altri)

BMIRE00030428 | Pages: 172 | Medical Device | Jul 2024 | Type: Regional | Status: Published
Il mercato europeo dei kit per test rapidi è stato valutato a 5.244,46 milioni di dollari nel 2022 e si prevede che raggiungerà i 7.763,57 milioni di dollari entro il 2030; si stima registrerà un CAGR del 5,0% dal 2022 al 2030.

Le iniziative strategiche dei produttori guidano il mercato europeo dei kit per test rapidi

I produttori nel mercato dei kit per test rapidi sottolineano l\'adozione di strategie come innovazioni, lanci e approvazioni di prodotti per mantenere un vantaggio competitivo sul mercato. Tali iniziative strategiche da parte delle aziende nel mercato dei kit di test rapidi avvantaggiano il mercato globale.

Nel 2022, il produttore di prodotti diagnostici con sede a Singapore INEX Innovate, pioniere nel settore della salute femminile e fetale in Asia, ha ricevuto il marchio CE per OvaCis Rapid Test, la sua soluzione di punta per il cancro ovarico. Entro la fine del 2022, si prevede che OvaCis, un test point-of-care (POCT) primo nel suo genere che distingue le cisti ovariche benigne da quelle maligne in sala operatoria, faccia il suo debutto nell’UE e nel Sud-Est asiatico. mercati.

Nel gennaio 2022, OraSure Technologies, Inc., leader globale nei test diagnostici al punto di cura e a domicilio, nonché nelle tecnologie di raccolta dei campioni, ha lanciato l\'autotest HIV OraQuick, un test basato su tampone orale in -test domiciliare per HIV-1 e HIV-2, per il mercato europeo. Il test è accessibile in sei paesi europei: Regno Unito, Francia, Germania, Italia, Spagna e Portogallo.

Nel 2021, in seguito al rilascio del certificato CE, FUJIFILM Europe GmbH è stata autorizzata ad applicare il marchio CE e a introdurre un kit di test antigenici per la diagnosi dell\'infezione da SARS-CoV-2. La tecnica utilizzata da Fujifilm è chiamata immunocromatografia brevettata con amplificazione dell\'argento e si basa sulla stessa tecnologia utilizzata per amplificare le foto da sviluppare.

Nel dicembre 2020, la Food and Drug Administration (FDA) statunitense ha rilasciato un\'autorizzazione all\'uso di emergenza (EUA) per un test rapido BinaxNOW COVID-19 Ag Card (di Abbott) guidato virtualmente, indicato per l\'uso a domicilio utilizzare per il rilevamento di COVID-19. BinaxNOW è un test rapido ampiamente distribuito e tra i più convenienti, che fornisce risultati in pochi minuti.

Nel luglio 2020, la FDA ha concesso l\'autorizzazione all\'uso di emergenza (EUA) per un test diagnostico rapido per SARS-CoV-2 presso il punto di cura da utilizzare con il suo sistema BD Veritor Plus ampiamente disponibile. Il nuovo test genera risultati in 15 minuti su uno strumento facile da usare e altamente portatile. Il test aveva lo scopo di migliorare l’accesso alla diagnostica COVID-19 fornendo risultati in tempo reale e favorendo un rapido processo decisionale mentre il paziente è ancora nella struttura del test.

Panoramica del mercato dei kit per test rapidi in Europa

La prevalenza del diabete in Germania è aumentata in modo significativo. Secondo l’International Diabetes Federation, nel 2021 circa 62 milioni di persone avevano il diabete. Inoltre, secondo il rapporto del Centro europeo per la prevenzione e il controllo delle malattie, nel 2019 sono stati registrati nell’Unione europea (UE) 8.641 casi di malaria, di cui 8.638 (>99%) erano diagnosi confermate. Nel settembre 2022, la Germania ha firmato un accordo del valore di 1,34 miliardi di dollari con il Programma congiunto delle Nazioni Unite sull\'HIV/AIDS (UNAIDS) volto a combattere l\'AIDS, la tubercolosi e la malaria; in questo modo, il Paese ha aumentato il proprio contributo del 30% rispetto al 2019. Inoltre, secondo il rapporto 2020 di endmalaria.org, fonti internazionali hanno fornito il 69% del finanziamento totale finalizzato al controllo e all’eliminazione della malaria. Il finanziamento totale per il controllo e l’eliminazione della malaria ammontava a 3,3 miliardi di dollari, compresi 0,2 miliardi di dollari forniti dalla Germania. Pertanto, è probabile che il mercato dei kit per test rapidi cresca in Germania nei prossimi anni con la crescente prevalenza di malattie infettive come il diabete, l’AIDS, la tubercolosi e la malaria.

Entrate e previsioni del mercato dei kit per test rapidi in Europa fino al 2030 (milioni di dollari)

Segmentazione del mercato dei kit per test rapidi in Europa

Il mercato dei kit per test rapidi in Europa è segmentato in base al tipo , prodotto, tecnologia, applicazione, utente finale e paese. In base alla tipologia, il mercato europeo dei kit per test rapidi è segmentato in test rapidi dell’antigene, test rapidi degli anticorpi e altri. Il segmento dei test rapidi per l\'antigene ha detenuto la quota di mercato maggiore nel 2022.

In termini di prodotto, il mercato europeo dei kit per test rapidi è biforcato in kit per test rapidi da banco e kit per test rapidi professionali. Il segmento dei kit per test rapidi da banco ha detenuto una quota di mercato maggiore nel 2022.

Per tecnologia, il mercato europeo dei kit per test rapidi è segmentato in test a flusso laterale, fase solida, agglutinazione, test immunospot e test cellulare basato sui componenti. Il segmento del test a flusso laterale ha detenuto la quota di mercato maggiore nel 2022.

In base all\'applicazione, il mercato europeo dei kit per test rapidi è classificato in test della glicemia, test di malattie infettive, gravidanza e fertilità, test cardiometabolici e altri. Il segmento dei test della glicemia ha detenuto la quota di mercato maggiore nel 2022.

In termini di utente finale, il mercato europeo dei kit per test rapidi è segmentato in ospedali e cliniche, assistenza domiciliare, centri diagnostici e altri. Il segmento ospedali e cliniche ha detenuto la quota di mercato maggiore nel 2022.

In base al paese, il mercato europeo dei kit per test rapidi è segmentato in Regno Unito, Germania, Francia, Italia, Spagna e resto d\'Europa. La Germania ha dominato la quota di mercato europea dei kit per test rapidi nel 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Sysmex Partec GmbH, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA e Beckman Coulter Inc sono alcuni dei principali attori che operano nel mercato europeo dei kit per test rapidi.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Rapid Test Kits Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Rising Prevalence of Genetic and Infectious Diseases

4.1.2 Strategic Initiatives by Manufacturers

4.2 Market Restraints

4.2.1 Uncertainties Related to Accuracy of Results

4.3 Market Opportunities

4.3.1 Increasing Preference for PCR Techniques

4.4 Future Trends

4.4.1 Innovations in Rapid Antigen Tests

4.5 Impact Analysis

5. Rapid Test Kits Market - Europe Market Analysis

5.1 Overview

5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

6. Europe Rapid Test Kits Market Analysis - by Type

6.1 Overview

6.2 Rapid Antigen Testing

6.2.1 Overview

6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

6.3 Rapid Antibody Testing

6.3.1 Overview

6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Others

6.4.1 Overview

6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Rapid Test Kits Market Analysis - by Product

7.1 Overview

7.2 Over-the-Counter Rapid Testing Kit

7.2.1 Overview

7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Professional Rapid Testing Kit

7.3.1 Overview

7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Rapid Test Kits Market Analysis - by Technology

8.1 Overview

8.2 Lateral Flow Assay

8.2.1 Overview

8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Solid Phase

8.3.1 Overview

8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Agglutination

8.4.1 Overview

8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Immunospot Assay

8.5.1 Overview

8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Cellular-Component Based

8.6.1 Overview

8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Rapid Test Kits Market Analysis - by Application

9.1 Overview

9.2 Blood Glucose Testing

9.2.1 Overview

9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9.3 Infectious Disease Testing

9.3.1 Overview

9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)

9.4 Cardiometabolic Testing

9.4.1 Overview

9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Pregnancy and Fertility

9.5.1 Overview

9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Rapid Test Kits Market Analysis - by End User

10.1 Overview

10.2 Hospital and Clinics

10.2.1 Overview

10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10.3 Diagnostic Centers

10.3.1 Overview

10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Home-Care

10.4.1 Overview

10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10.5 Others

10.5.1 Overview

10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Rapid Test Kits Market - Country Analysis

11.1 Europe

11.1.1 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country

11.1.1.1 Germany

11.1.1.1.1 Overview

11.1.1.2 Germany: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.1 Germany: Rapid Test Kits Market Breakdown, by Type

11.1.1.2.2 Germany: Rapid Test Kits Market Breakdown, by Product

11.1.1.2.3 Germany: Rapid Test Kits Market Breakdown, by Technology

11.1.1.2.4 Germany: Rapid Test Kits Market Breakdown, by Application

11.1.1.2.4.1 Germany: Rapid Test Kits Market Breakdown, by Infectious Disease Testing

11.1.1.2.5 Germany: Rapid Test Kits Market Breakdown, by End User

11.1.1.3 United Kingdom

11.1.1.3.1 Overview

11.1.1.4 United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11.1.1.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Type

11.1.1.4.2 United Kingdom: Rapid Test Kits Market Breakdown, by Product

11.1.1.4.3 United Kingdom: Rapid Test Kits Market Breakdown, by Technology

11.1.1.4.4 United Kingdom: Rapid Test Kits Market Breakdown, by Application

11.1.1.4.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Infectious Disease Testing

11.1.1.4.5 United Kingdom: Rapid Test Kits Market Breakdown, by End User

11.1.1.5 France

11.1.1.5.1 Overview

11.1.1.6 France: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11.1.1.6.1 France: Rapid Test Kits Market Breakdown, by Type

11.1.1.6.2 France: Rapid Test Kits Market Breakdown, by Product

11.1.1.6.3 France: Rapid Test Kits Market Breakdown, by Technology

11.1.1.6.4 France: Rapid Test Kits Market Breakdown, by Application

11.1.1.6.4.1 France: Rapid Test Kits Market Breakdown, by Infectious Disease Testing

11.1.1.6.5 France: Rapid Test Kits Market Breakdown, by End User

11.1.1.7 Italy

11.1.1.7.1 Overview

11.1.1.8 Italy: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11.1.1.8.1 Italy: Rapid Test Kits Market Breakdown, by Type

11.1.1.8.2 Italy: Rapid Test Kits Market Breakdown, by Product

11.1.1.8.3 Italy: Rapid Test Kits Market Breakdown, by Technology

11.1.1.8.4 Italy: Rapid Test Kits Market Breakdown, by Application

11.1.1.8.4.1 Italy: Rapid Test Kits Market Breakdown, by Infectious Disease Testing

11.1.1.8.5 Italy: Rapid Test Kits Market Breakdown, by End User

11.1.1.9 Spain

11.1.1.9.1 Overview

11.1.1.10 Spain: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11.1.1.10.1 Spain: Rapid Test Kits Market Breakdown, by Type

11.1.1.10.2 Spain: Rapid Test Kits Market Breakdown, by Product

11.1.1.10.3 Spain: Rapid Test Kits Market Breakdown, by Technology

11.1.1.10.4 Spain: Rapid Test Kits Market Breakdown, by Application

11.1.1.10.4.1 Spain: Rapid Test Kits Market Breakdown, by Infectious Disease Testing

11.1.1.10.5 Spain: Rapid Test Kits Market Breakdown, by End User

11.1.1.11 Rest of Europe

11.1.1.11.1 Overview

11.1.1.12 Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11.1.1.12.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Type

11.1.1.12.2 Rest of Europe: Rapid Test Kits Market Breakdown, by Product

11.1.1.12.3 Rest of Europe: Rapid Test Kits Market Breakdown, by Technology

11.1.1.12.4 Rest of Europe: Rapid Test Kits Market Breakdown, by Application

11.1.1.12.4.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Infectious Disease Testing

11.1.1.12.5 Rest of Europe: Rapid Test Kits Market Breakdown, by End User

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Rapid Test Kit Market

12.3 Inorganic Growth Strategies

12.3.1 Overview

12.4 Organic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 F. Hoffmann-La Roche Ltd

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Becton Dickinson and Co

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 ARKRAY Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Sysmex Partec GmbH

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Fujirebio Europe NV

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 bioMerieux SA

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Cepheid

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Meril Life Sciences Pvt Ltd

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 QIAGEN NV

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 OraSure Technologies Inc

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

13.11 Guangzhou Wondfo Biotech Co Ltd

13.11.1 Key Facts

13.11.2 Business Description

13.11.3 Products and Services

13.11.4 Financial Overview

13.11.5 SWOT Analysis

13.11.6 Key Developments

13.12 Denka Co Ltd

13.12.1 Key Facts

13.12.2 Business Description

13.12.3 Products and Services

13.12.4 Financial Overview

13.12.5 SWOT Analysis

13.12.6 Key Developments

13.13 Abbott Laboratories

13.13.1 Key Facts

13.13.2 Business Description

13.13.3 Products and Services

13.13.4 Financial Overview

13.13.5 SWOT Analysis

13.13.6 Key Developments

13.14 Trinity Biotech Plc

13.14.1 Key Facts

13.14.2 Business Description

13.14.3 Products and Services

13.14.4 Financial Overview

13.14.5 SWOT Analysis

13.14.6 Key Developments

13.15 Bio-Rad Laboratories Inc

13.15.1 Key Facts

13.15.2 Business Description

13.15.3 Products and Services

13.15.4 Financial Overview

13.15.5 SWOT Analysis

13.15.6 Key Developments

13.16 Hologic Inc

13.16.1 Key Facts

13.16.2 Business Description

13.16.3 Products and Services

13.16.4 Financial Overview

13.16.5 SWOT Analysis

13.16.6 Key Developments

13.17 DiaSorin SpA

13.17.1 Key Facts

13.17.2 Business Description

13.17.3 Products and Services

13.17.4 Financial Overview

13.17.5 SWOT Analysis

13.17.6 Key Developments

13.18 Premier Medical Corp Pvt Ltd

13.18.1 Key Facts

13.18.2 Business Description

13.18.3 Products and Services

13.18.4 Financial Overview

13.18.5 SWOT Analysis

13.18.6 Key Developments

13.19 Beckman Coulter Inc

13.19.1 Key Facts

13.19.2 Business Description

13.19.3 Products and Services

13.19.4 Financial Overview

13.19.5 SWOT Analysis

13.19.6 Key Developments

14. Appendix

14.1 About The Insight Partners

List of Tables

Table 1. Rapid Test Kits Market Segmentation

Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Table 3. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 4. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 5. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology

Table 6. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 7. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing

Table 8. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 9. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 10. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 11. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology

Table 12. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 13. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing

Table 14. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 15. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 16. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 17. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology

Table 18. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 19. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing

Table 20. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 21. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 22. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 23. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology

Table 24. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 25. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing

Table 26. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 27. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 28. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 29. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology

Table 30. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 31. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing

Table 32. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 33. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 34. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 35. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology

Table 36. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 37. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing

Table 38. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 39. Recent Inorganic Growth Strategies in the Rapid Test Kit Market

Table 40. Recent Organic Growth Strategies in the Rapid Test Kit Market

List of Figures

Figure 1. Rapid Test Kits Market Segmentation, By Country

Figure 2. Rapid Test Kits Market: Key Industry Dynamics

Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints

Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)

Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)

Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)

Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)

Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)

Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 29. Europe: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)

Figure 30. Europe: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 31. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)

Figure 32. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)

Figure 33. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)

Figure 34. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)

Figure 35. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)

Figure 36. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)

Figure 37. Growth Strategies in the Rapid Test Kit Market

1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. Sysmex Partec GmbH
4. ARKRAY Inc
5. Fujirebio Europe NV
6. bioMerieux SA
7. Cepheid
8. Meril Life Sciences Pvt Ltd
9. QIAGEN NV
10. OraSure Technologies Inc
11. Guangzhou Wondfo Biotech Co Ltd
12. Denka Co Ltd
13. Abbott Laboratories
14. Trinity Biotech Plc
15. Bio-Rad Laboratories Inc
16. Hologic Inc
17. Premier Medical Corp Pvt Ltd
18. DiaSorin SpA
19. Beckman Coulter Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe rapid test kit market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe rapid test kit market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440